RecruitingNCT06521229

Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation


Sponsor

AstraZeneca

Enrollment

9,000 participants

Start Date

Jun 27, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a multi-centre, non-interventional, observational, ambispective registry. Planned study population consists of 9 000 adult patients with uncontrolled asthma receiving treatment according to standard of care (except biologics). Planned number of study site is 70 outpatient centers with experience of uncontrolled asthma treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled asthma in different regions in the most comprehensive way).


Eligibility

Plain Language Summary

Simplified for easier understanding

This observational registry study in Russia is collecting detailed information about patients with uncontrolled mild-to-moderate asthma — their demographics, medical history, symptoms, and treatments — to better understand this population. **You may be eligible if...** - You are 18 or older - You have been diagnosed with uncontrolled mild or moderate asthma (as defined by GINA guidelines) - You have at least 52 weeks of follow-up records in your medical file - You are willing to sign informed consent **You may NOT be eligible if...** - You have severe asthma or are currently receiving biologic therapy (or received it in the past year) - You also have COPD or idiopathic pulmonary fibrosis - You are currently participating in another clinical trial or did so in the past year - You have another medical condition that, in the doctor's judgment, affects your ability to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(47)

Research Site

Astrakhan, Russia

Research Site

Blagoveshchensk, Russia

Research Site

Bryansk, Russia

Research Site

Chelyabinsk, Russia

Research Site

Gatchina, Russia

Research Site

Irkutsk, Russia

Research Site

Ivanovo, Russia

Research Site

Izhevsk, Russia

Research Site

Kazan', Russia

Research Site

Kemerovo, Russia

Research Site

Krasnodar, Russia

Research Site

Krasnoyarsk, Russia

Research Site

Lipetsk, Russia

Research Site

Makhachkala, Russia

Research Site

Moscow, Russia

Research Site

Murmansk, Russia

Research Site

Nal'chik, Russia

Research Site

Nizhny Novgorod, Russia

Research Site

Nizhny Tagil, Russia

Research Site

Novokuznetsk, Russia

Research Site

Novosibirsk, Russia

Research Site

Omsk, Russia

Research Site

Omsk, Russia

Research Site

Orenburg, Russia

Research Site

Perm, Russia

Research Site

Petrozavodsk, Russia

Research Site

Pyatigorsk, Russia

Research Site

Rostov-on-Don, Russia

Research Site

Ryazan, Russia

Research Site

Saint Petersburg, Russia

Research Site

Saint Petersburg, Russia

Research Site

Samara, Russia

Research Site

Saratov, Russia

Research Site

Smolensk, Russia

Research Site

Stavropol, Russia

Research Site

Surgut, Russia

Research Site

Tomsk, Russia

Research Site

Tula, Russia

Research Site

Ufa, Russia

Research Site

Ulan-Ude, Russia

Research Site

Verkhnyaya Pyshma, Russia

Research Site

Vladimir, Russia

Research Site

Vladivostok, Russia

Research Site

Voronezh, Russia

Research Site

Yaroslavl, Russia

Research Site

Yekaterinburg, Russia

Research Site

Yuzhno-Sakhalinsk, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06521229


Related Trials